FRANKFURT--The following is a summary of analysts' forecasts for
Sanofi SA (SNY) second-quarter results, based on a poll of seven
analysts conducted by Dow Jones Newswires (figures in million
euros, EPS, dividend and target price in euro, according to IFRS).
Earnings figures are scheduled to be released July 30.
===
Business Business
Net Sales Operating Net
2nd Quarter Sales Lantus Income Income EPS
AVERAGE 8,968 1,716 2,378 1,700 1.31
Prev. Year 8,075 1,557 2,145 1,537 1.17
+/- in % +11 +10 +11 +11 +12
MEDIAN 9,047 1,720 2,386 1,705 1.31
Maximum 9,193 1,775 2,455 1,759 1.34
Minimum 8,561 1,666 2,258 1,639 1.26
Amount 7 5 7 6 7
Bernstein 9,103 1,666 2,379 1,696 1.30
Cowen and Company 8,915 1,775 2,455 1,759 1.34
Credit Suisse 9,047 -- 2,428 -- 1.33
Exane BNP Paribas 8,876 1,739 2,386 1,713 1.31
J.P. Morgan 9,193 -- 2,430 1,736 1.33
Jefferies 9,078 1,720 2,309 1,654 1.27
Morgan Stanley 8,561 1,679 2,258 1,639 1.26
Target price Rating DPS 2015
AVERAGE 101.17 positive 2 AVERAGE 2.97
Prev. Quarter 99.25 neutral 4 Prev. Year 2.85
+/- in % +1.9 negative 1 +/- in % +4.1
MEDIAN 99.50 MEDIAN 3.00
Maximum 107.00 Maximum 3.13
Minimum 98.00 Minimum 2.63
Amount 6 Amount 5
Bernstein 107.00 Outperform 2.63
Citi 99.00 Neutral --
Deutsche Bank 105.00 Buy 3.00
Exane BNP Paribas 98.00 Neutral 2.99
J.P. Morgan -- Underweight --
Jefferies 98.00 Hold 3.13
Morgan Stanley 100.00 Equalweight 3.08
===
Year-earlier figures are as reported by the company.
DJG/mus
Subscribe to WSJ: http://online.wsj.com?mod=djnwires